Recent Updates
Recently added Catalysts
PROF Negative Sentiment Score: 40/100

EXECUTION COPY INFORMATION IN THIS EXHIBIT IDENTIFIED BY [***] IS CONFIDENTIAL AND HAS BEEN EXCLUDED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSE

Key Takeaway: Profound Medical Inc. has excluded certain confidential information from public disclosure, claiming it is not material and could cause competitive harm. The details pertain to a credit agreement among the company and its subsidiaries with the Canadian Imperial Bank of Commerce for a maximum credit amount of up to $10,000,000. While this funding could support operational needs, the lack of transparency may lead to concerns regarding investor confidence and competitive positioning in the market.

Market Sentiment Analysis

CONCERNS & RISKS

  • The information excluded from disclosure could suggest potential vulnerabilities in the company's operations or strategy.
  • Confidentiality may raise concerns about transparency and investor confidence.
  • The nature of competitive harm implies that the company may be facing significant competitive pressures.

Full Press Release Details

INFORMATION IN THIS EXHIBIT IDENTIFIED BY [***] IS CONFIDENTIAL
AND HAS BEEN EXCLUDED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF
PROFOUND MEDICAL INC.
PROFOUND MEDICAL CORP.
2753079 ONTARIO INC.
PROFOUND MEDICAL (U.S.) INC. and
PROFOUND MEDICAL GMBH
CANADIAN IMPERIAL BANK OF COMMERCE
Article I. Interpretation 1
Section 1.01 Definitions 1
Section 1.02 PPSA 20
Section 1.03 Headings 21
Section 1.04 References to Sections 21
Section 1.05 Currency 21
Section 1.06 Gender and Number 21
Section 1.07 Invalidity of Provisions 21
Section 1.08 Transition from GAAP to US GAAP 21
Section 1.09 Amendment or Waiver 21
Section 1.10 Non-Business Days 22
Section 1.11 Currency Equivalents 22
Section 1.12 German Terms 22
Article II. The Loans 23
Section 2.01 The Commitments 23
Section 2.02 Loans 23
Section 2.03 Fees 23
Section 2.04 Payment; Computation 23
Section 2.05 Loan Account 23
Article III. Payments and Prepayments 24
Section 3.01 Repayment of Loans 24
Section 3.02 Interest 24
Section 3.03 End of Term Payment 25
Section 3.04 Optional Prepayments 25
Section 3.05 Mandatory Prepayments 26
Section 3.06 Application of Prepayments 27
Section 3.07 Notice of Prepayments 27
Section 3.08 Payments Generally 27
Section 3.09 Change in Law and Increased Costs 28
Section 3.10 Taxes 29
Section 3.11 Illegality 31
Article IV. Security 31
Section 4.01 Security Documents 31
Section 4.02 Control of Collateral; Control Agreements 32
Section 4.03 Guarantors 32
Section 4.04 Real Estate 32
Section 4.05 Delivery of Additional Documentation Required 33
Section 4.06 Right to Inspect 33
Article V. Representations and Warranties 33
Section 5.01 Incorporation and Status 33
Section 5.02 Corporate Power and Due Authorization 34
Section 5.03 Business of the Loan Parties 34
Section 5.04 No Contravention 34
Section 5.05 Not Insolvent 34
Section 5.06 Approvals and Consents 35
Section 5.07 Welfare and Pension Plans 35
Section 5.08 Changes Since Date of Financial Statements 35
Section 5.09 No Default Under Agreements 36
Section 5.10 Title to Assets 36
Section 5.11 Financial Matters 36
Section 5.12 No Material Adverse Change 37
Section 5.13 Environmental Matters 37
Section 5.14 Assets in Good Condition 37
Section 5.15 Licenses and Agreements 37
Section 5.16 Tax Matters 37
Section 5.17 Insurance 38
Section 5.18 Intellectual Property 38
Section 5.19 Permits 39
Section 5.20 Regulatory Required Permits 39
Section 5.21 Compliance with Laws and Litigation 39
Section 5.22 Material Facts Disclosed 40
Section 5.23 No Rights to Acquire Assets 40
Section 5.24 No Rights to Provide Financial Advisory Services 40
Section 5.25 Chief Executive Office and Location of Assets 40
Section 5.26 Minute Books 40
Section 5.27 Use of Proceeds; Margin Stock 41
Section 5.28 Investment Company Act 41
Section 5.29 Bank Accounts 41
Section 5.30 Shares and Corporate Structure 41
Section 5.31 Liabilities 42
Section 5.32 Employee Matters 42
Section 5.33 Non-Arm's Length Transactions 43
Section 5.34 Description of Real Property 43
Section 5.35 Sanctions 43
Section 5.36 Anti-Terrorism and Anti-Money Laundering Laws 44
Article VI. Covenants 44
Section 6.01 Use of Proceeds 44
Section 6.02 Payment of Principal and Interest; Secured Obligations 44
Section 6.03 Lender Expenses 44
Section 6.04 Compliance with Laws; Permits; Corporate Existence 44
Section 6.05 Delivery of Collateral and Perfection 45
Section 6.06 Collateral 45
Section 6.07 Operating Leases 45
Section 6.08 Insurance 45
Section 6.09 Transactions with Affiliates 45
Section 6.10 Material Agreement 46
Section 6.11 Reporting 46
Section 6.12 Healthcare Regulatory Matters 46
Section 6.13 Accounts 47
Section 6.14 Sanctions 47
Section 6.15 Anti-Terrorist Financing and Anti-Money Laundering Laws 47
Section 6.16 Negative Covenants 48
Section 6.17 Maintenance of Records 49
Section 6.18 Notices 49
Section 6.19 Limitations on Modifications, Waivers, Extensions 50
Section 6.20 Financial Covenants 50
Section 6.21 Intellectual Property 50
Section 6.22 Pension Plans 51
Section 6.23 Material Subsidiaries 51
Section 6.24 Centre of Main Interests 52
Section 6.25 Post-Closing Obligations 52
Article VII. Conditions 52
Section 7.01 Conditions Precedent to the Initial Extension of Credit 52
Section 7.02 Conditions Precedent to all Extensions of Credit 54
Article VIII. Events of Default 54
Section 8.01 Events of Default 54
Section 8.02 Lender's Remedies Upon Default 57
Section 8.03 Lender Protective Payments 58
Section 8.04 Remedies Cumulative 58
Section 8.05 Power of Attorney 58
Section 8.06 Notice of Event of Default 59
Section 8.07 Default under Other Encumbrances 59
Section 8.08 Judgment 59
Section 8.09 Application of Proceeds 59
Section 8.10 Limitation of Liability 60
Section 8.11 Borrower Liable 60
Article IX. Benchmark Replacement Setting 60
Section 9.01 Benchmark Replacement Setting 60
Article X. General 65
Section 10.01 Releases 65
Section 10.02 Governing Law; Jurisdiction; Jury Trial Waiver and Judicial Reference 65
Section 10.03 Whole Agreement 66
Section 10.04 Time 66
Section 10.05 Notices 66
Section 10.06 Successors and Assigns 67
Section 10.07 Indemnification 68
Section 10.08 No Set-Off 68
Section 10.09 Permitted Encumbrance 68
Section 10.10 Press Releases 68
Section 10.11 Confidentiality 68
Section 10.12 Judgment Currency 69
Section 10.13 Anti-Money Laundering Legislation 69
Section 10.14 Counterparts 70
CREDIT AGREEMENT (as amended, restated, supplemented or otherwise modified from time to time, the "Agreement")
dated as of November 3, 2022, by and among Profound Medical Inc., an Ontario corporation, as borrower ("Borrower"),
Profound Medical Corp., an Ontario corporation, as a guarantor ("Parent"), 2753079 Ontario Inc., an Ontario
corporation, as a guarantor ("275 Ontario"), Profound Medical GmbH, a German limited liability company (Gesellschaft
mit beschr nkter Haftung), as a guarantor ("PM Germany") Profound Medical (U.S.) Inc., a Delaware corporation,
as a guarantor ("PM USA"), and Canadian Imperial Bank of Commerce, as lender ("Lender").
the Borrower has requested that Lender extend credit to it in a maximum aggregate principal amount of up to $10,000,000 for the various
purposes set out herein.
the Borrower is a wholly-owned subsidiary of Parent and PM Germany and PM USA are each a wholly-owned subsidiary of the Borrower.
Parent, PM Germany and PM USA have agreed to guarantee the obligations of the Borrower hereunder.
WHEREAS Lender is willing to extend such credit on and subject to the terms and conditions hereof.
THEREFORE in consideration of the covenants and agreements herein the parties hereto agree as follows:
Section 1.01 Definitions
the meaning set forth in the preamble to this Agreement.
means a person obligated on an Account.
meaning given to such term in the PPSA.
"Acquisition" means,
with respect to any Person, any purchase or other acquisition by such Person, regardless of how accomplished or effected (including any
such purchase or other acquisition effected by way of amalgamation, merger, arrangement, business combination or other form of corporate
reorganization or by way of purchase, lease or other acquisition arrangements), of (a) any other Person (including any purchase or
acquisition of such number of the issued and outstanding securities of, or such portion of an Equity Interest in, such other Person so
that such other Person becomes a Subsidiary of the purchaser or of any of its Affiliates) or of all or a material portion of the Property
of any other Person, or (b) any division, business, operation or undertaking of any other Person or of all or a material portion
of the Property of any division, business, operation or undertaking of any other Person or (c) any material real estate asset.
"Additional Documents"
has the meaning set forth in Section 4.05.
with respect to any Person, another Person that directly, or indirectly through one or more intermediaries, Controls or is Controlled
by or is under common Control with the Person specified.
"Agreement," "hereto,"
"herein," "hereof," "hereby," "hereunder," and any similar
expressions refer to this Agreement and the schedules attached hereto and not to any particular article, section or other portion hereof,
and include any and every instrument supplemental hereto or amending or replacing any part hereof.
means, in respect of any Person, property, transaction, event or other matter, as applicable, all Laws relating or applicable to such
Person, property, transaction, event or matter.
"Anti-Terrorist Financing and
Anti-Money Laundering Laws" means all Applicable Law concerning or related to money laundering or financing terrorism and which
are applicable to the Lender, any Loan Party or any Affiliate thereof, including the Proceeds of Crime (Money Laundering) and Terrorist
Financing Act (Canada) and all similar laws, rules, regulations and other Applicable Laws in place in any foreign country, including
has the meaning set forth in Section 6.15.
"Board" means a Person's
board of directors, board of managers, board of members or similar governing body, provided that, unless otherwise specified, "Board"
shall refer to the applicable Loan Party's Board.
meaning set forth in the preamble to this Agreement.
consolidated and consolidating projections and budget, prepared annually on a monthly basis, for Parent and its Subsidiaries adopted and
approved by Parent's Board for the given period.
"Business Day" means
a day other than a Saturday, Sunday or any other day on which banks located in the City of Toronto, Province of Ontario are not open for
and "$" mean lawful money of Canada.
"Canadian Guarantee"
has the meaning set forth in Section 4.01(b).
"Canadian IP Security Agreement"
has the meaning set forth in Section 4.01(d).
"Canadian Pension Plan"
means any "pension plan" that is subject to the funding requirements of the Pension Benefits Act (Ontario) or applicable
pension benefits legislation in any other Canadian jurisdiction.
"Canadian Security Agreement"
has the meaning set forth in Section 4.01(a).
"Capital Lease" means
any lease that would be considered to be a capital lease in accordance with GAAP; provided, that any lease that would be considered to
be an operating lease in accordance with GAAP on the date of this agreement shall not be considered to be a Capital Lease notwithstanding
any change in GAAP after such date that may reclassify it as a capital lease.
means (a) marketable direct obligations issued or unconditionally guaranteed by the United States, the Government of Canada or any
agency or any state or province, as applicable, thereof having maturities of not more than one (1) year from the date of acquisition;
(b) commercial paper maturing no more than one (1) year after its creation and having the highest rating from either Standard &
Poor's Ratings Group or Moody's Investors Service, Inc.; (c) certificates of deposit issued maturing no more than
one (1) year after issue; (d) money market funds at least ninety-five percent (95%) of the assets of which constitute Cash Equivalents
of the kinds described in clauses (a) through (c) of this definition; and (e) comparable instruments as those
described in clauses (a) through (d) for any Loan Party that is not formed under the federal or provincial laws
of Canada and operates in a jurisdiction outside of Canada.
means, with respect to any Property of any Person, any loss of or damage to, or any condemnation or other taking of, such Property for
which such Person or any of its Subsidiaries receives insurance proceeds, or proceeds of a condemnation award or other compensation.
any date, the annual rate of interest which is the rate based on an average rate applicable to Canadian Dollar bankers' acceptances
for a specified term appearing on the "Refinitiv Screen CDOR Page" (as defined in the International Swaps and Derivatives
Association, Inc., definitions, as modified and amended from time to time) at approximately 10:00 a.m. (Toronto time), on such
date, or if such date is not a Business Day, then on the immediately preceding Business Day, provided that if such rate does not
appear on the Refinitiv Screen CDOR Page on such date as contemplated, then CDOR on such date shall be the rate for the term referred
to above applicable to Canadian Dollar bankers' acceptances quoted by the Lender as of 10:00 a.m. (Toronto time) on such date
or, if such date is not a Business Day, then on the immediately preceding Business Day; provided further, that if CDOR is less
than zero, it shall be deemed to be zero hereunder.
"Centre of Main Interests"
means the "centre of main interests" of a Loan Party incorporated in a member state of the European Union as that term is
used in Article 3(1) of Regulation (EU) 2015/848 of the European Parliament and of the Council of 20 May 2015 on insolvency
proceedings (recast).
of Control" means, unless otherwise waived in writing by Lender, (a) the consummation of any transaction (including,
without limitation, any plan of arrangement, merger, amalgamation or consolidation) the result of which is that any Person or group of
Persons acquires or otherwise beneficially owns, directly or indirectly, or acquires or has the voting power and/or investment power in
respect of, 50% or more of the Shares of Parent; (b) the first day on which a majority of the members of the Board of the Parent
are not Continuing Directors; or (c) if any Loan Party that is a Subsidiary of Parent ceases to be a wholly-owned Subsidiary of Parent

Frequently Asked Questions

What is the maximum loan amount mentioned in the agreement?

The maximum loan amount is up to $10,000,000.

Who are the primary parties involved in the agreement?

The primary parties are Profound Medical Inc. and the Canadian Imperial Bank of Commerce.

What type of companies are Profound Medical GmbH and Profound Medical (U.S.) Inc.?

They are wholly-owned subsidiaries of Profound Medical Inc.

Which laws govern the agreement's provisions?

The agreement is governed by relevant laws applicable to the involved parties.

What document details the loan commitments and repayments?

The loan commitments and repayments are outlined in the Credit Agreement.

Last updated: May 1, 2023